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AAV infection
DNA damage responsesDuring adeno-associated virus and adenovirus (AAV/Ad) coinfection, accumulation of viral genomes and
proteins can alter cellular stress responses. To determine how AAV/Ad coinfection affects the host we
screened over 60 cellular proteins for their responses. AAV/Ad coinfections induce a robust DNA damage
response (DDR) that is distinct from that induced by Ad infection alone. Using chemical inhibitors, deﬁcient
cell lines and siRNA knockdowns of the DDR kinases, ATM, ATR and DNA-PK, we determined that DNA-PK
and ATM kinases are the initial transducers of this response. AAV/Ad coinfection induces ATM- and DNA-PK
mediated phosphorylation of RPA2, NBS1, H2AX and the checkpoint kinases CHK1/2. Inhibition of one or
more of the DDR kinases reduces the level of phosphorylation of downstream targets but does not
dramatically reduce Ad or AAV protein expression. However, AAV DNA levels are moderately affected by
kinase inhibition. These experiments provide new insights into the cellular responses to AAV/Ad
coinfections.© 2009 Elsevier Inc. All rights reserved.IntroductionAdeno-associated virus (AAV) belongs to the Parvoviridae family
and the Dependovirus genus (Muzyczka and Berns, 2001). AAV is
classiﬁed as a Dependovirus because it depends upon coinfection of
another virus to efﬁciently propagate itself. AAV replicates most
efﬁciently with an adenovirus (Ad) coinfection, but varying levels of
helper functions are provided by other DNA viruses. The helper virus
dependence is not absolute and AAV replicates at low levels when
cultured cells are treated with genotoxic agents (Yakobson et al., 1989,
1987; Yalkinoglu et al., 1988). The 4680 nucleotide, single-stranded
AAV2 genome contains 145 bp inverted terminal repeat (ITR)
elements that form unique T-shaped hairpins at each end. The 3′ ITR
serves as the primer for DNA replication and the single-strand genome
is converted to a double strand conformation by cellular DNA
polymerases. The AAV genome contains two translation open reading
frames encoding four replication (Rep) proteins and three capsid
(Cap) proteins. Expression of the largest Rep protein, Rep78, is
detectable approximately 4 h after infection and the remaining Rep
proteins appear 8–12 h post-infection (Redemann, Mendelson, and
Carter, 1989). Replicative form (RF) AAV DNA is detectable approxi-
mately 10 h post-infection and Cap proteins accumulate as AAV DNA is
replicated. AAV RF DNA accumulates up to 105 copies per infected celland Cancer Biology, Mail Stop
o, 3000 Arlington Ave., Toledo,
pe).
ll rights reserved.nucleus (Rose and Koczot, 1972). Recombinant AAV (rAAV) vectors are
under intense study for treating a variety of acquired and hereditary
diseases (Carter, Burstein, and Peluso, 2004).
Ad helper functions are provided by several early gene proteins
that enhance AAV replication (Muzyczka and Berns, 2001). E1a
proteins activate transcription of Ad early genes as well as AAV rep
and cap genes (Chang, Shi, and Shenk, 1989). E1a proteins induce
entry of the host cell into S-phase, which enables Ad and AAV
replication. E1b-55k and E4orf6 proteins form a complex involved
in the conversion of single- to double-stranded DNA and the
transport of AAV mRNA from the nucleus to the cytoplasm
(Samulski and Shenk, 1988). E4orf6 is also involved in cell cycle
arrest by inhibiting CDC2 kinase and enhancing Cyclin A degrada-
tion (Grifman et al., 1999). This function may explain how rAAV
vectors are converted to a double-stranded conformation by co-
expression of E4orf6 (Ferrari et al., 1996; Fisher et al., 1996). E2a
single-stranded DNA binding protein (ssDBP) enhances AAV
elongation and is the only Ad protein proposed to play a direct
role in AAV replication (Ward et al., 1998). E2a ssDBP also
stimulates AAV gene expression (Chang and Shenk, 1990).
Host cells respond to virus infection in multiple ways to defend
themselves from the deleterious effects of viral proteins and
replicating viral nucleic acids. Several reviews have nicely summar-
ized these studies (Weitzman et al., 2004; Weitzman and Ornelles,
2005). A series of cellular sensors and signal transduction pathways
are activated by different types of DNA damage as well as by the
accumulation of replicating viral DNA. Ataxia telangiectasia mutated
(ATM), ATM-Rad3 related (ATR) or double strand DNA-activated
protein kinase (DNA-PK) are considered the initial responders to
Fig. 1. AAV/Ad-mediated DDR responses in Hela cells. Hela cells were treated with UV
light (UV), left untreated (No), infected with Ad, or coinfected with AAV and Ad. UV-
treated cultures were harvested 1 h after irradiation. Infected cells were harvested at 6,
12, 18, 24 and 36 h after infection. Cells were fractionated and equal amounts of protein
were separated by SDS-PAGE and immunoblotted with the antibodies indicated to the
left of the ﬁgure.
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al., 2005; Zhou et al., 2006). They belong to the phosphoinositide 3-
kinase-related kinase (PI3K) family of kinases. These kinases act as
signal transducers phosphorylating a variety of substrates required for
DNA damage and repair (DDR). ATM and ATR are activated upon
recruitment to the DNA lesion by the MRN complex of proteins. The
MRN complex, comprised of MRE11, RAD50 and NBS1, is one of the
primary sensors that detect double strand breaks. While the exact
mechanism of DSB recognition has not been deﬁned, it is proposed
that MRN interacts with the DSBs and recruits one or more of the PI3-
like protein kinases. Activation of ATM and or ATR sets off a cascade of
phosphorylation events that direct the cessation of cell cycle
progression, DNA repair or apoptosis. DNA-PK is another major player
in the nonhomologous end joining pathway (Collis et al., 2005). The
components of this pathway, DNA-PK, Ku70/80, Artemis, XRCC4 and
DNA ligase IV are active in V(D)J immunoglobulin gene rearrange-
ment. The ability of DNA-PK to function as a DDR signal transducer is
evident in its multiple substrates and roles in DNA repair, apoptosis,
telomere maintenance and innate immunity (Burma and Chen, 2004;
Collis et al., 2005).
In an Ad infection, accumulation of replicating viral DNA results
in activation of the nonhomologous end joining (NHEJ) DNA repair
pathway leading to concatemerization of Ad DNA and inhibition of
viral replication. The (DDR) response is overcome when Ad
inactivates NHEJ by targeting the Mre11-Rad50-NBS1 (MRN)
complex for degradation. Using a series of Ad mutants and cell
lines deﬁcient for different DNA repair proteins, the Weitzman
group showed that Ad E4 proteins inactivate the MRN complex
thus preventing the NHEJ repair pathway from concatemerizing
replicating Ad genomes (Carson et al., 2003; Stracker et al., 2002).
The MRN complex allowed for concatemer formation of E4 mutant
viruses and colocalized to Ad replication centers. Unlike Ad E4
mutants, wild type Ad genomes did not concatemerize and
mediated limited ATM activation. Thus the virus encodes factors
that block concatemer formation and the DNA damage response.
Two redundant functions encoded by the Ad E4 orf3 and orf6
proteins mediate these effects (Araujo et al., 2005; Evans and
Hearing, 2005; Liu et al., 2005; Stracker et al., 2005). A unique
characteristic of the E4orf3 protein is the reorganization of
promyelocytic leukemia (PML) organizing domains (PODs) which
have been implicated in a variety of cellular processes (Maul,
1998). E4 orf3 redirects the MRN complex to cytoplasmic
aggresomes thus preventing their participation in NHEJ (Evans
and Hearing, 2005). The E4 orf6 protein forms a complex with the
E1b 55K protein that interacts with Elongins B and C, Cullin 5 and
additional proteins to form an E3 ubiquitin-protein ligase that
ubiquitinates one or more members of the MRN thus targeting
them for degradation (Carson et al., 2003; Liu et al., 2005; Stracker
et al., 2002). The E1b 55K-E4orf6 complex also directs the
degradation of p53, which is a well characterized player in the
DNA repair response (Harada et al., 2002; Querido et al., 2001). Ad
infection also leads to degradation of DNA ligase IV (Baker et al.,
2007). Thus the inactivation of cellular DDR responses is essential
for a productive Ad infection.
Here we show that AAV/Ad coinfections induce a robust DDR
response that is distinct from that induced by Ad infection alone.
Using cell lines deﬁcient for PI3 family kinases, drug-inhibition
studies and siRNA knockdown experiments we show that DNA-PK
and ATM are the principal signal transducers of this response
resulting in phosphorylation of multiple downstream targets
including the CHK1/2 kinases, RPA2, NBS1 and histone H2AX.
Inhibition of ATM or ATR results in decreased AAV replication
whereas inhibition of DNA-PK results in an increase in virus
replication. These studies show that AAV and Ad coinfections
trigger cellular DNA damage responses that affect the ability of
the virus to replicate itself.Results
Induction of a DDR response in AAV/Ad coinfected cultures
To determine how the combined effects of AAV and Ad coinfection
alter the host cell we initiated a survey of cellular protein and
phosphoprotein levels. Hela cells were infected with Ad at a multi-
plicity of infection (m.o.i.) of 5 and AAV at an m.o.i. of 100. Cultures
were harvested at 6, 12, 18, 24 and 36 h. At harvest, cellular extracts
were prepared, proteins were separated by SDS-PAGE, transferred to
nylon membrane and probed with antibodies speciﬁc to over 60
cellular proteins. Subtle differences were observed in the levels of
several cell cycle regulation proteins. Cyclin B levels decreased slightly
in AAV/Ad coinfected cells compared to Ad-infected cells whereas p21
increased slightly (data not shown). These changes have been noted
previously by others (Saudan et al., 2000). One consistent change we
have observed is that Cyclin A levels are consistently reduced in AAV/
Ad coinfected cells compared to Ad-infected cells (Fig. 1).
The most striking changes were observed in cellular proteins
involved in the DNA damage and repair response (Fig. 1). In Ad-
Fig. 2. DDR response in Hela cells infected with AAV, rAAV and Ad. Hela cells were left
uninfected (No) or were infected with Ad, a recombinant AAV vector (rAAV), wild type
AAV (wtAAV) or combinations thereof. Cultures were harvested 24 h after infection;
lysates were prepared and analyzed by immunoblots using the antibodies indicated on
the left side of the ﬁgure. UV-irradiated Hela cells (UV) were used as a positive control.
26 R.F. Collaco et al. / Virology 392 (2009) 24–33infected cultures there was an increase in activated ATM, as
determined by phosphorylation on Ser1981. However in AAV/Ad
coinfected cultures there was a much stronger activation of ATM
beginning at 12 h post-infection. Activation of ATM is one of the initial
signaling events in response to double strand DNA breaks (Lavin et al.,
2005; Shiloh, 2006). ATM activation was accompanied by a strong
activation of the checkpoint kinases, CHK1 and CHK2 on Ser348 and
Thr68 respectively (Fig. 1). In Ad-infected cultures there was less
activation of CHK2. There was also no effect on the level of total CHK2
under any of the infection conditions. CHK1 was activated as
measured by phosphorylation on S345 and occurs at the same time
point as CHK2 activation. We have yet to observe a repeatable
difference in the total levels of Chk2 (Fig. 1) or CHK1 (data not shown)
between Ad and AAV/Ad infections (data not shown). However
MRE11, RAD50 and NBS1 levels decreased as the infection progressed
for both Ad and AAV/Ad coinfected cultures as has been observed by
others in Ad-infected cells (Carson et al., 2003; Stracker et al., 2002).
AlthoughNBS1 levels decreased during AAV/Ad coinfection, therewas
a dramatic increase in the amount of NBS1 that is phosphorylated on
Ser343 beginning at the 12 h time point (pNBS1 in Fig. 1).
Replication protein A (RPA) is a single-stranded (ss) DNA
binding protein required for DNA replication, repair and homo-
logous recombination. RPA is a heterotrimer composed of subunits
of 70 (RPA1), 34 (RPA2) and 14 kD (RPA3), During UV- and IR-
induced DNA damage responses, RPA is hyper-phosphorylated by
members of the PI3-related kinase family (Wold, 1997). Hyperpho-
sphorylation occurs primarily on the 34 kD RPA2 subunit and can be
detected by altered mobility in SDS-PAGE. We have found that RPA2
mobility is altered in AAV/Ad coinfected cells and is ﬁrst detected at
the 12 h time point (Fig. 1). Altered RPA mobility is not observed in
Ad-infected cells. Other immunoblot analyses using antibodies
speciﬁc for phosphorylated Ser4 and Ser8 in RPA2, indicate that
these residues are indeed phosphorylated in response to AAV/Ad
coinfection (results not shown).
The cellular p53 tumor suppressor protein is a pivotal component
in the cellular response to cellular stressors such as DNA damage
(Meek, 2004). Both genotoxic and nongenotoxic stressors induce and
stabilize p53 resulting in changes in expression of p53-responsive
genes. Ad infection mediates degradation of p53 thus allowing the
virus to counteract p53's role in a variety of responses (Harada et al.,
2002; Querido et al., 2001). However, in AAV/Ad coinfection there is a
modest stabilization of p53 levels (Fig. 1). While the change in p53
stabilization is not as dramatic a change as that of the other DNA repair
proteins, this change may contribute to the AAV-mediated cellular
response to infection.
DNA damage causes phosphorylation of histone H2AX by the PI3-
like kinases ATM, ATR and DNA-PK (Stucki and Jackson, 2006).
Phosphorylated H2AX (γH2AX) contributes to DNA repair by inter-
acting with DNA ﬂanking the lesion. Although its role in repair is not
fully understood it is thought to link the DNA damage response
machinery to the lesion-containing DNA. Ad infection stimulates
H2AX phosphorylation whereas the stimulation is more pronounced
in an AAV/Ad coinfection (Fig. 1).
The AAV/Ad-mediated DDR response is dependent upon wild type virus
coinfection
The DDR responsewasmore pronounced in an AAV/Ad coinfection
than in the absence of AAV. The response may be due to the combined
effects of the AAV virion and Ad. Alternatively, a productive AAV
infection may be required to cause the DDR response. To further
characterize the DDR response, Hela cells were infected with AAV or a
recombinant AAV vector alone or in combination with Ad infection.
18–24 h post-infection, the cultures were harvested and analyzed by
immunoblot to assess ATM, NBS1, CHK1/2, RPA2 and H2AX phos-
phorylation. AAV at an m.o.i. of 100 or rAAV at the same m.o.i. did notinduce phosphorylation of ATM, NBS1 or CHK1/2 (Fig. 2, lanes 2 and 4
respectively). NBS1 was phosphorylated when cells are infected with
Ad alone, Ad plus a rAAV vector or Ad plus AAV coinfection (Fig. 2,
lanes 2, 5 and 6). However these infection conditions did not affect
ATM or CHK1/2 phosphorylation. Histone H2AX was slightly
phosphorylated with Ad, rAAV, wtAAV and Ad plus rAAV (lanes 2–
5). Themost robust DDR responsewas observed only with AAV and Ad
coinfection in which all 5 proteins were phosphorylated (lane 6). The
slight increase in H2AX induced with rAAV and wtAAV may represent
the earliest stages of the DDR response and that as AAV genomes
accumulate in a coinfection, the full DDR response results. Although
Ad coinfection with rAAV vectors results in efﬁcient conversion of the
single-strand vector DNA to a double strand conformation (Ferrari et
al., 1996; Fisher et al., 1996), this was not sufﬁcient to induce the full
DDR response. To test whether ectopic AAV Rep protein expression in
conjunction with Ad infection induces the DDR response, we
transfected Rep-expressing plasmids into Ad-infected Hela cells. 24–
48 h after transfection, the cultures were harvested and analyzed by
immunoblot for phosphorylated ATM and CHK2. These experiments
did not show any activation of the ATM or CHK2 kinases (data not
shown). This suggests that Rep protein expression, when combined
with Ad infection, does not induce the DDR response. Ampliﬁcation of
the AAV DNA in the presence of Ad is essential to trigger the signal
transduction cascade.
Pharmacological inhibition of ATM and DNA-PK activity in AAV/Ad
coinfected cells
To assess the roles of the DDR kinases in the host cell responses to
AAV/Ad coinfection we used chemical inhibitors of ATM (KU55933,
Hickson et al., 2004) and DNA-PK (NU7441, Leahy et al., 2004). We
have used these compounds in Hela cells to determine how they may
inhibit phosphorylation of downstream targets of ATM, ATR and DNA-
PK. Hela cells were treated with the inhibitors 2 h before infection and
up until cultures were harvested 24 h later. Cellular extracts were
prepared and immunoblotted to assess levels of phosphorylated
CHK1, CHK2, NBS1, H2AX and RPA. Fig. 3 shows that activation of CHK1
Fig. 4. AAV/Ad-mediated DDR responses in ATM-deﬁcient cell lines. ATM-expressing
(ATM+) or ATM-deﬁcient (ATM−) cells were left uninfected (No), infected with Ad
(Ad) or coinfected with AAV and Ad (Co). Parallel cultures were similarly infected and
treated with NU7441 4 h prior to infection. Cultures were harvested 18–24 h later,
cellular lysates prepared and analyzed by immunoblots using the antibodies indicated
on the left side of the ﬁgure.
Fig. 3. AAV/Ad-mediated DDR response in Hela cells treated with ATM and DNA-PK
inhibitors. Hela cells were left uninfected (No), infectedwith Ad (Ad) or coinfectedwith
AAV and Ad (Co). Parallel cultures were Ad or AAV/Ad coinfected and treated with PI3
kinase inhibitors (Inhib.), KU55933 (KU), NU7441 (NU) or both drugs (NU/KU) 4 h
prior to infection. Cultures were harvested 18–24 h later, cellular lysates prepared and
analyzed by immunoblots using the antibodies indicated on the left side of the ﬁgure.
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DNA-PK inhibitor, NU7441 (NU) (lane 7). When both NU and KUwere
used, activation of CHK1 was totally inhibited (lane 9). This result
suggests that DNA-PK and ATM are involved in phosphorylation of
CHK1. CHK2 was inhibited by the DNA-PK inhibitor (NU) (lane 7), but
there was only slight inhibition from the ATM inhibitor alone (KU)
(lane 5). Combining NU7441 and KU55933 resulted in complete
inhibition of CHK2 activation (lane 9). This result suggests that DNA-
PK may be a signiﬁcant activator of CHK2 in AAV/Ad coinfection.
There was a modest level of phosphorylation of NBS1 in Ad-
infected cells (Figs. 1–3) and a more prominent phosphorylation in
AAV/Ad coinfected cells. When ATM was inhibited with KU55933,
phosphorylation of NBS1 was totally blocked in Ad-infected cells
and reduced in AAV/Ad coinfected cultures (Fig. 3, compare lanes 4
and 5). When DNA-PK is inhibited by NU7441, NBS1 phosphoryla-
tion was not affected in Ad-infected cells (lane 6) whereas it was
reduced in AAV/Ad coinfected cells (lane 7) compared to the drug-
free infection (lane 3). When both ATM and DNA-PK were inhibited
by NU7441 and KU55933, all NBS1 phosphorylation was inhibited
(lanes 8 and 9). Although these experiments are not strictly
quantitative, the results suggest that ATM mediates phosphorylation
of NBS1 in Ad infections and DNA-PK mediates NBS1 phosphoryla-
tion in AAV-infected cells.
The slower migrating band of RPA2, which is the result of
phosphorylation, was not affected by KU55933 (lane 5) but was
partially inhibited by NU7441 (lane 7). This result suggests that DNA-
PK phosphorylates RPA but that another kinase, perhaps ATR, also
modiﬁes this cellular, single-strand DNA binding protein.
The effects of these small molecule inhibitors on Ad and AAV
gene expression was determined by assessing the levels of AAV Rep
and Cap proteins and Ad E2A. There were no apparent effects on
E2A, AAV Rep and Cap proteins in all of the drug treatments. This
result suggests that AAV protein expression is not dependent on
DNA-PK or ATM activity.The AAV/Ad DDR response in ATM-deﬁcient cells
To complement the drug studies described above, we assessed DDR
response signaling in cell lines lacking the ATM kinase. GM16666 and
GM16667 are ﬁbroblast cell lines from an ATM−/− patient and are
transformed by the SV40 T-Ag. GM16667 contains an ATM expression
plasmidwhereasGM16666 contains the emptycloning vector (Ziv et al.,
1997). Using the same infection and analysis procedures described
above we found that AAV/Ad coinfections induced CHK1/2 and NBS1
phosphorylation in both the ATM-restored and ATM-deﬁcient cell lines
(Fig. 4, lanes 3 and 6, respectively).Howeverwhen theDNA-PK inhibitor
(NU7441) was used in these cell lines, CHK1 phosphorylation was
reduced in the ATM-restored cells and eliminated in the ATM-deﬁcient
cells. CHK2phosphorylationwas completely inhibited in coinfected cells
in the presence of the DNA-PK inhibitor (lanes 9 and 12). NBS1
phosphorylationwas reduced in the ATM-restored cell line (lane 9) and
abolished in the ATM-deﬁcient cells (lane 12) in the presence of the
DNA-PK inhibitor. Phosphorylated RPA was observed in both ATM cell
lines but was eliminated in the presence of NU7441. There were no
detectable changes in γH2AX. AAV and Ad gene expression were not
affected by the absence of ATM, or ATM with inhibition of DNA-PK.
The AAV/Ad DDR response in DNA-PK-deﬁcient cells
To complement the studies described above, we assessed the DDR
response in cell lines lacking DNA-PK. MO59J cells are derived from a
glioblastoma cell line that lack DNA-PK. MO59K cells were isolated
from the same tumor and express normal levels of DNA-PK (Allalunis-
Turner et al., 1993). AAV/Ad infections of the DNA-PK-containing cells
induced phosphorylation of CHK1/2, RPA, γH2AX and NBS1 (Fig. 5,
lane 3). Coinfections in cells lacking DNA-PK had reduced CHK1, NBS1
and γH2AX phosphorylation (Fig. 5, lane 6). Whereas in DNA-PK-
deﬁcient cells there was no detectable CHK2 or RPA phosphorylation
and there was also a reduction in NBS1 phosphorylation (Fig. 5, lane
6). In DNA-PK-containing MO59K cells treated with the ATM inhibitor,
KU55933, there was a reduction in NBS1 phosphorylation and a slight
Fig. 6. AAV/Ad-mediated DDR responses in ATR-FLOX cells. ATR-FLOX cells were
infected with the Ad-CMV-Gal or Ad-Cre virus vectors at an MOI of 100. 60 h later the
cells were left uninfected (No), infected with Ad (Ad) or coinfected with AAV and Ad
(Co). Cultures were harvested 18–24 h later; cellular lysates were prepared and
analyzed by immunoblots using the antibodies indicated on the left side of the ﬁgure.
Fig. 5. AAV/Ad-mediated DDR responses in DNA-PK-deﬁcient cell lines. MO59K, DNA-
PK-expressing cells (K) or MO59J DNA-PK-deﬁcient (J) glioblastoma cells were left
uninfected (No), infected with Ad (Ad) or coinfected with AAV and Ad (Co). Parallel
cultures were similarly infected and treated with KU55933 4 h prior to infection.
Cultures were harvested 18–24 h later; cellular lysates were prepared and analyzed by
immunoblots using the antibodies indicated on the left side of the ﬁgure.
Fig. 7. AAV/Ad-mediated DDR responses in siRNA-treated Hela cells. Hela cells were
transfectedwith control siRNA (Cont.) or siRNAs designed to suppress ATM, ATR andDNA-
PK expression using the protocol described in the Materials and methods section. Cells
were left uninfected (No), infected with Ad (Ad) or coinfected with AAV and Ad (Co).
Cultures were harvested 18–24 h after virus infection and cellular lysates were prepared
and analyzed by immunoblots using the antibodies indicated on the left side of the ﬁgure.
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phorylation was not affected (lane 9). NBS1, RPA and H2AX
phosphorylation were eliminated in AAV/Ad-infected DNA-PK-deﬁ-
cient cells treated with the ATM inhibitor (lane 12). CHK1 phosphor-
ylation was substantially reduced under these conditions. AAV Cap
and Ad E2A protein expression was not affected in the absence of
DNA-PK or the absence of DNA-PK and ATM.
The AAV/Ad DDR response in ATR-FLOX cells
To determine if ATR plays a role in the AAV/Ad-mediated DDR
responsewe performed similar experiments in ATR-FLOX cells (Cortez
et al., 2001). These cells are derived from HCT116 cells in which one
copy of the ATR gene has been disrupted, and the second copy of the
gene contains lox sites ﬂanking exon 2 making it susceptible to Cre-
mediated deletion. Preliminary experiments showed that infection of
ATR-FLOX cells with a Cre-expressing Ad vector (Ad-Cre) three days
prior to AAV/Ad coinfection was the time required for maximal
reduction of ATR expression resulting in up to 90% reduction [data not
shown and Cortez et al., 2001]. Reduction of ATR expression by the Ad-
Cre vector is evident in Fig. 6 (lanes 5 and 6). ATR levels were not
affected when ATR-FLOX cells were infected with an Ad control vector
that expresses the E. coli β-galactosidase gene instead of Cre (Fig. 6
lanes 2 and 3). Therewas no difference in the levels of phosphorylation
of ATM, CHK2, NBS1, RPA or H2AX when comparing the Ad-Cre-
treated, ATR-deﬁcient, with the Ad-CMV-Gal-treated AAV/Ad coin-
fected cultures. The only noticeable difference in the AAV/Ad DDR
response was a reduction of CHK1 phosphorylation in the Ad-Cre-
treated cultures. As observed in the other cell lines, there were
negligible effects on Ad E2A or AAV Rep and Cap protein expression.
The AAV/Ad DDR response in Hela cells transfected with siRNAs that
target ATM, ATR and DNA-PK
As an alternative means of kinase suppression Hela cells were
transfected with siRNAs that target ATM, ATR and DNA-PK. Cells weretransfectedwith siRNAon three successive days prior to virus infection
and a fourth transfection after infection. 24 h after AAV/Ad infection
the cultures were harvested and assessed for phosphorylation of
cellular DDR proteins. Fig. 7 shows that we attained nearly 100%
reduction of ATR expression (lanes 8 and 9), approximately 75%
Fig. 8. AAV DNA ampliﬁcation in siRNA-treated Hela cells. Hela cells were transfected
with control siRNA (Cont.) or siRNAs designed to suppress ATM, ATR and DNA-PK
expression using the protocol described in the Materials and methods section. Cells
were left uninfected (No), infected with Ad (Ad) or coinfected with AAV and Ad (Co).
Cultures were harvested 18–24 h after virus infection, viral DNA was prepared and
analyzed by agarose gel electrophoresis and Southern hybridization (A) or real-time
PCR (B). Replicative form monomer (M) and dimer (D) DNAs are indicated to the right
of the image in panel A.
Fig. 9. Localization of AAV Rep and cellular DDR proteins. Hela cells growing in chamber
slides were coinfected with AAV and Ad. 24 h post-infection the cultures were ﬁxed and
treated with primary and secondary antibodies to detect the proteins indicated below
each panel. Merged images on the right are indicated.
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(lanes 10 and 11) compared to cells transfected with control siRNA
(lanes 4 and 5). When ATM expression was suppressed, phosphoryla-
tion of CHK1/2, NBS1 and RPA were reduced compared to the control
siRNA transfection (compare lanes 5 and 7).When DNA-PK expression
was suppressed therewas a reduction of CHK1/2, NBS1, RPA andH2AX
phosphorylation (lane 11). When ATR expression was suppressed,
phosphorylation of CHK2, NBS1 and RPA were reduced (lane 9)
compared to the control siRNA. However CHK1, and perhaps RPA,
phosphorylation was reduced more in the absence of ATR than when
ATM and DNA-PKwere suppressed (compare lane 9 to lanes 7 and 11).
There were no signiﬁcant effects on E2A or Rep expression in these
experiments. However there was a slight reduction in Cap expression
when ATM was suppressed (lane 7).
To assess the effects of DDR kinases on AAV DNA replication,
parallel siRNA transfections and AAV/Ad coinfections were performed
accompanied by treatment with the Ku55933 ATM or Nu4771 DNA-PK
inhibitors. 24 h after infection, low molecular weight DNA was
prepared and analyzed by Southern hybridization after agarose gel
electrophoresis. Fig. 8A shows that when siRNAs targeting ATM or ATR
are transfected there was a reduction in replicative form monomer
(M) AAV DNA compared to control siRNA transfection. However
siRNA-mediated knockdown of DNA-PK resulted in an increase in AAV
RF DNA. When siATR transfection was accompanied by Ku55933-
mediated inhibition of ATM, there was a further inhibition of AAVreplication. However when ATR was reduced by siRNA and DNA-PK
was inhibited by Nu4771, there was an increase in AAV replication
suggesting that the effects on DNA-PK may be dominant compared to
ATR suppression.
To quantitatively assess the effects of kinase inhibition, the isolated
AAV DNA from Fig. 8A was analyzed by real-time PCR. Knockdown of
ATM by siRNA or inhibition by Ku55933 resulted in an approximate 6-
fold reduction of viral DNA compared to control siRNA transfection
(Fig. 8B). Knockdown of DNA-PK by siRNA transfection or inhibition
by Nu4771 resulted in an approximate 2–3-fold stimulation of AAV
DNA replication compared to the control siRNA transfection.
“Our observations are consistent with similar experiments per-
formed in DNA-PK- and ATM-deﬁcient cell lines. AAV DNA replication
in DNA-PK-deﬁcient cells was consistently higher than in the
corresponding DNA-PK-containing cells. However replication was
consistently lower in ATM-deﬁcient cells compared to ATM-proﬁcient
cells (data not shown).”
Cellular localization of cellular DNA repair proteins and AAV Rep in
coinfected cells
To investigate the localization of cellular DNA repair proteins in
AAV/Ad coinfections, Hela cells were coinfected, ﬁxed 24 h later and
immuno-stained for Rep, and the cellular proteins. The Ad E4 orf3
protein redirects the MRN complex out of the nucleus and into
cytoplasmic aggresomes thus preventing their participation in NHEJ
(Evans and Hearing, 2005). Immunoﬂuorescent staining ofMRE11 and
RAD50 in coinfected cells shows that AAV does not alter this
relocalization. Both MRE11 and RAD50 show punctate staining that
is primarily cytoplasmic whereas Rep staining is nuclear (Fig. 9).
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with the Rep proteins (Fig. 9). This colocalization suggests that
phosphorylated NBS1 may be found in AAV replication centers and
thus play a role in the coinfection. We also examined the cellular
localization of the AAV Rep protein, ATM and DNA-PK. As described
above, both of these kinases are activated by AAV/Ad coinfection. Rep
and ATM showed some colocalization in AAV/Ad coinfected nuclei.
Rep and DNA-PK showed abundant colocalization in coinfected cells.
The signiﬁcant colocalization of DNA-PK with Rep proteins suggests
that the kinase plays a role in viral DNA replication.
Discussion
During an AAV/Ad coinfection there is a dramatic accumulation of
AAV RF genomes that have a covalently closed DNA end and a free DNA
end. The accumulation of over 105 AAV genomes per infected cell
(Rose and Koczot, 1972), as well as the expression of the cytotoxic Rep
proteins, would likely have signiﬁcant effects on the cell stress
response. Our increasing understanding of how Ad affects the cellular
DNA damage response is in stark contrast towhat little is known about
this response when AAV accompanies Ad in a coinfection; there have
been no studies performed that examine if AAV alters Ad effects on the
host cell. Studies with recombinant AAV (rAAV) vectors performed in
the absence of Ad infection have shown that treatment of cells with
DNA damaging agents, UV light, topoisomerase inhibitors and
hydroxyurea; stimulate vector transduction (Alexander et al., 1994,
1996; Russell et al., 1995; Sanlioglu et al., 1999). DDR repair pathways
are involved in the regulation of rAAV transduction efﬁciency. Using
chromatin immunoprecipitation methods, Zentilin et al. showed that
Ku86 and RAD52 proteins associated with rAAV DNA (Zentilin et al.,
2001). Sanlioglu et al. showed that rAAV transduction efﬁciency is
increased in ATM-deﬁcient ﬁbroblasts (Sanlioglu et al., 2000).
Recombinant AAV vectors form circular episomes upon transduction
and this process depends upon functional ATM, DNA-PK, MRE11, NBS1
and the helicases BLM and WRN (Choi et al., 2006; Sanlioglu et al.,
2000). The DNA-PK pathway also affects AAV integration and
circularization of recombinant AAV vectors (Duan et al., 2003; Inagaki
et al., 2007; Song et al., 2004). The relevance of these vector studies to
AAV/Ad coinfections remains to be determined.
Another study showed that UV-irradiated AAV or undamaged AAV,
when introduced into cells in culture induces a single-strand DNA
damage response with the activation of ATR signaling (Fragkos et al.,
2008). Finally, one report links ectopic expression of the AAV Rep
protein with ATM activation but the mechanism of this activation was
not determined (Berthet et al., 2005). The relevance of these studies to
our results may be limited because neither involve AAV and Ad
coinfections.
The studies presented here were designed to assess host cell
responses to AAV/Ad coinfection. We screened over 60 cellular
proteins for how they respond to coinfection. Our initial efforts
focused on cell cycle regulatory proteins andwe looked for differences
in the overall levels of these proteins in AAV/Ad coinfections
compared to Ad infection alone. The only consistent changes we
observedweremodest decreases in the levels of p21, p53 and Cyclin A.
The Cyclin A decrease has been observed in cells infected with AAV
Rep protein-expressing retroviruses and may play a role in the Rep
protein's ability to block cell cycle proliferation (Saudan et al., 2000).
Suppression of Cyclin A may contribute to cell cycle alterations during
AAV/Ad coinfections.
Themost dramatic changes observedwere in proteins known to be
altered in the cellular DNA damage responses. We observed increased
phosphorylation of ATM, CHK1/2, RPA2, H2AX and NBS1 as the AAV
infection progressed. ATM phosphorylation on Ser1981, CHK2 on
Thr68 and CHK1 on Ser343 are all considered activating events that
trigger subsequent phosphorylations of downstream targets in the
DDR (Lavin et al., 2005; Shiloh, 2006). Activation of ATM is one of theinitial signaling events in response to double strand DNA breaks.
Activation of ATM, as determined by phosphorylation on Ser1981, has
been observed in Ad-infected cultures (Carson et al., 2003). We also
observed a similar activation in Ad-infected cultures however in AAV/
Ad coinfected cultures there was a much stronger activation of ATM
beginning at 12 h post-infection. This response corresponds with the
accumulation of Rep proteins and AAV RF DNA (Redemann et al., 1989)
suggesting that the accumulation of AAV RF DNAmay trigger the DDR.
That active AAV replication is required for the response is further
demonstrated in Fig. 2 where Ad infection alone stimulated
phosphorylation of NBS1 but wild type AAV and Ad coinfection was
required to elicit phosphorylation of all of the substrates that we
studied.
Recently the MRN complex was shown to impede AAV replication
and that MRN components accumulate at AAV replication centers in
the absence of Ad infection (Schwartz et al., 2007). Our results show
that MRE11, RAD50 and NBS1 levels decreased as the infection
progressed for both Ad and AAV/Ad coinfected cultures as has been
observed by others in Ad-infected cells (Carson et al., 2003; Stracker et
al., 2002). There was essentially no difference in the effects on the
MRN complex in an AAV/Ad coinfection compared to Ad infection
alone. Thus in a coinfection, the inhibition of AAV replication
described by Schwartz et al. would not be observed because of the
ability of Ad to suppress MRN functions.
Although NBS1 levels decreased during AAV/Ad coinfection, there
was a dramatic increase in the amount of NBS1 that is phosphorylated
on Ser343 beginning at the 12 h time point. Phosphorylation of NBS1
by ATM is involved in the activation of the S-phase checkpoint but was
not required for association with the other members of the MRN
complex at DNA damage sites (Lavin, 2007). The role of phosphory-
lated NBS1 and whether it associates with AAV DNA remains to be
determined.
The diversity of substrates phosphorylated in response to AAV/Ad
infection suggested that other members of the PI3 family kinases
including DNA-PK and ATR, may also be involved in AAV/Ad-mediated
DNA damage responses. Due to an absence of reliable antibodies that
recognize activate ATR and DNA-PK, we used several approaches to
identify the kinases that initiate the AAV/Ad-mediated DDR. Pharma-
cological inhibition of PI3 family kinases has been dependent on the
relatively nonspeciﬁc inhibitors, caffeine, wortmannin and LY294002.
Several new inhibitors have been identiﬁed that block kinase activity
with more speciﬁcity. NU7441 is a selective inhibitor of DNA-PK
(IC50=14 nM) (Leahy et al., 2004). KU55933 is a selective inhibitor of
ATM (IC50=13 nM) (Hickson et al., 2004). Using these compounds in
combination with cell lines that lack the PI3 family kinases and siRNA
knockdown experiments we were able to determine which of these
kinases are involved in the AAV/Ad DDR. DNA-PK is the predominant
kinase that responds to AAV/Ad coinfection in that it apparently
phosphorylates all ﬁve of the downstream substrates of the PI3
kinases (Fig. 10). Although ATM can phosphorylate both CHK1/2 in a
coinfection, DNA-PK is the predominant modiﬁer of the checkpoint
kinases that transduce the DDR to other substrates. Activation of the
ATR kinase appears to play only aminor role in response to coinfection
in that it is involved only in CHK1 phosphorylation.
The Rep proteins are found throughout the nucleus of AAV/Ad
coinfected cells. Early in infection, regions of the nucleus contain foci
of Rep proteins and AAV DNA that are sites of virus replication and
assembly (Bevington et al., 2007; Hunter and Samulski, 1992;
Weitzman et al., 1996). Our observation that the AAV Rep proteins
co-localize with DNA-PK, and to a lesser extent with ATM, suggests
that these kinases play some role in AAV replication or assembly.
“DNA-PK is known to phosphorylate numerous proteins involved in
DNA repair and recombination (Burma and Chen, 2004; Collis et al.,
2005). We also have preliminary evidence that DNA-PK phosphor-
ylates the AAV Rep78 protein on Ser197 (data not shown). We have
also shown that phosphorylation of the AAV Rep proteins alters their
Fig. 10. Signal transduction induced by AAV replication. An AAV replicative form
monomer with a trimer of attached Rep proteins is indicated at the top of the ﬁgure.
AAV replication activates initial DDR kinases which in turn results in phosphorylation of
downstream substrates.
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2002). Thus this regulation may play an essential role in viral DNA
replication.”
Our results demonstrate a robust cellular DDR response to AAV/Ad
coinfection. Surprisingly, elimination of one or two of the PI3 kinases
had only a modest effect on viral DNA replication. Removal of ATM
alone results in a 2–10-fold decrease in AAV replication. Removal of
DNA-PK results in a modest 2–3-fold increase in replication. Removal
of ATR results in a 0–2-fold decrease. The loss of ATR can be counter-
acted by pharmacological suppression of DNA-PK resulting in an
overall increase in replication. We have not yet been successful in
obtaining adequate reductions of all three kinases to assess AAV DNA
replication under those conditions. The mechanism of how the
reduction of ATM and DNA-PK affect virus replication is not clear. As
noted earlier, rAAV vector circularization and integration depend upon
functional ATM, DNA-PK, MRE11, NBS1 and the helicases BLM and
WRN (Choi et al., 2006; Duan et al., 2003; Inagaki et al., 2007;
Sanlioglu et al., 2000; Song et al., 2004). Loss of DNA-PK would result
in less circularization and possiblymore DNA replication. How the loss
of ATM results in a decrease in replication remains to be seen.
These studies present the ﬁrst evidence of DNA damage and repair
responses that occur in cells coinfected with AAV and Ad. The
response is distinctly different from that observed in Ad-infected
cultures. Further characterization of these responses along with the
identiﬁcation of other substrates modiﬁed by the PI3 and checkpoint
kinases will provide valuable insights into how AAV replicates to very
high titers in coinfected cells.
Materials and methods
Cell lines
Hela cells (American Type Culture Collection) were grown as a
monolayer at 37 °C (5% CO2 atmosphere) in Eagle's minimum
essential medium (MEM) supplemented with 10%(v/v) fetal bovine
serum (FBS), 2 mM L-glutamine, 25 U/mL penicillin, 25 μg/mL
streptomycin, 2.5 μg/mL amphotericin B, and 100 μg/mL gentami-
cin. SV40-transformed AT cell lines, GM16666 and GM16667, were
obtained from the Coriell Institute. GM16667 were derived from
GM16666 and carry an ATM gene expression vector that corrects the
AT−/− phenotype (Ziv et al. Oncogene 15:159 '97). AT cells were
grown in DMEM containing high glucose, 10%(v/v) fetal bovine
serum (FBS), 2 mM L-glutamine, 25 U/mL penicillin, 25 μg/mL
streptomycin, 2.5 μg/mL amphotericin B, 100 μg/mL gentamicin and100 μg/mL of hygromycin. MO59J (lacking DNA-PK) and MO59K
(normal DNA-PK) cells were obtained from American Type Culture
Collection (ATCC) and were grown in MEM (containing Earle's Salts)
with 2.5 mM L-glutamine and supplemented with 0.05 mM non-
essential amino acids, 15% FBS, 25 U/mL penicillin, 25 μg/mL
streptomycin, 2.5 μg/mL amphotericin B and 100 μg/mL gentamicin.
ATR-FLOX cells (CRL-2780) were obtained from ATCC and were
propagated in McCoy's 5A medium containing 10% FBS, 25 U/mL
penicillin, 25 μg/mL streptomycin, 2.5 μg/mL amphotericin B
and100 μg/mL gentamicin.
Virus preparation and infections
AAV2 and Ad5 were prepared by methods previously described
(Carter et al., 1979; Casper et al., 2005; Winters and Russell, 1971). Ad
infections were performed at a multiplicity of infection (m.o.i.) of 1 or
5. AAV infections were performed at an m.o.i. of 50 or 100. Ad-CRE
(Cat. No. 1700) and Ad-CMV-Gal (Cat. No. 1080) were obtained form
Vector Biolabs.
UV treatment
For UV treatment of cells, the media was carefully removed and
saved in a sterile tube. Cells were washed gently with Phosphate
Buffered Saline (PBS). The PBS was aspirated and the cells were UV-
treated at 100 mJ/cm2 in a UV-Stratalinker (Stratagene). In case of
multi-well plates, the untreated wells (containing media) were
covered with aluminum foil. After cross-linking, the media was
added back to the dish and the cells were incubated for another 2–21/
2 h at 37 °C before harvesting and extraction.
Drug treatment
The ATM inhibitor (KU55933) and the DNA-PK inhibitor (NU7441)
were kindly provided by Dr. Graeme Smith (KuDOS Pharmaceuticals,
Cambridge, UK). The inhibitors were added to cells where indicated
(ﬁnal concentration of 10 μM) 4 h prior to infection and left on for the
duration of the experiment.
Immunoblot analyses
Cells were harvested 18–20 h post-infection and extracts were
prepared depending on the protein to be detected. ATM, ATR, DNA-
PK, Mre11, Rad50, pNbs1, Nbs1, Chk2, pChk2, AAV Rep/Cap and
Adenovirus E2a proteins were detected using the IPP (Immunopre-
cipitation) buffer extraction. Chk1, pChk1, p53, p34 and γH2A.X were
detected using 1× SDS Sample Buffer (Cell Signaling) extraction
method as described below. For IPP extracts, cells were resuspended
(150 μl per 1.2 million cells) in chilled IPP Buffer [50 mM Tris
(pH=8), 150 mM NaCl, 20 mM EDTA, 0.5% NP-40, 20 mM DTT;
pH=8] supplemented with protease and phosphatase inhibitors
[1 mm PMSF, 1 μg/ml Pepstatin A, 1 mM Benzamidine, 10 μM
Leupeptin, 1 mM Sodium orthovanadate, 1 mM Sodium ﬂuoride,
1 mM Sodium pyrophosphate, 1.75 mM B-glycerophosphate]. The
suspensions were vortexed vigorously for 15 s and kept on ice for
60 min with occasional vortexing. Extracts were sonicated for 6×1 s
pulses at level 3 (Fisher Scientiﬁc Sonic Dismembrator). Extracts
were centrifuged at 16,000 ×g for 10 min at 4 °C. Supernatants were
separated from pellets and protein assays were performed to
determine protein concentration. For Denaturing extracts, cells
were resuspended (150 μl per 1.2 million cells) in 1× SDS sample
Buffer [62.5 mM Tris–HCl (pH=6.8), 2% SDS, 10% glycerol, 50 mM
DTT, 5% B-ME, 0.01% bromophenol blue]. Lysates were vortexed
brieﬂy and sonicated (12×1 s pulses: level 4). Extracts were heated
to 100 °C in a water bath for 10 min and allowed to cool for 5 min.
Extracts were centrifuged at 16,000 ×g for 10 min at RT. Supernatants
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determine protein concentration. For western blots of P-I-3 kinases,
8% polyacrylamide (stock=49:1, acrylamide:bisacrylamide) SDS gels
were used. For the remaining proteins, 10% polyacrylamide
(stock=29:1, acrylamide:bisacrylamide) SDS gels were used. Wes-
tern blots were performed using different antibodies according to the
manufacturer's recommendations.
Antibodies
The following antibodies were used for western blot analysis:
ATM (A300-135A, Bethyl Laboratories Inc.), p-ATM (200-301-400,
Rockland), ATR (SC-1887, Santa Cruz Biotechnology), DNA-PK (sc-
9051, Santa Cruz Biotechnology, Inc.), Rad50 (GTX70228, GeneTex,
Inc.), Mre11 (GTX70212, GeneTex, Inc.), Nbs-1 (GTX70224, GeneTex,
Inc.), p-Nbs1 (sc-12936-R, Santa Cruz Biotechnology, Inc.), Chk2
(KAM-CC-1113, Assay Designs), pChk2 (2661S, Cell Signaling
Technology), Chk1 (KAM-CC-111, Assay Designs), p-Chk1 (2348S,
Cell Signaling Technology), p53 (OP09-100 μg, Calbiochem), RPA/
p34 (MS-691-P1ABX , Thermo Scientiﬁc) Actin (sc-1615 Santa Cruz
Biotechnology, Inc.), AAV Cap (Mouse monoclonal, Intergen), AAV
Rep (Rabbit polyclonal, Rockland), Ad E2a (Dr. Tom Shenk), γH2A.X
(ab18311, Abcam).
siRNA transfection
The siRNA transfectionswere performedusingHiPerfect transfection
reagent (Qiagen) according to the manufacturer's protocol. The siRNAs
were prepared according to the manufacturers (Qiagen) recommenda-
tion; ATM (Hs_ATM_8; SI00604730), ATR (Hs_ATR_12; SI02664347),
DNA-PK (Hs_PRKDC_6; SI02224236), Control (1022076). The cells were
sequentially transfected four times and the viral infections were
performed just before the ﬁnal transfection. The cells were harvested
and extra-chromosomal DNAwas isolated using a QIAampDNAmini kit
(Qiagen) and used for real-time PCR as described below.
Real-time PCR
Replicative genome copy number was determined by quantitative
real-time PCR of wt AAV genomes. Primers for PCR were designed to
amplify a 301 bp fragment. The forward primer was 5′-
AACTGGTTCGCGGTCACAA-3′ (AAV nt 708) and the reverse primer
was 5′-ACCCGACCAGCTCCATGTAC-3′ (AAV nt 1008). Primers were
used at a concentration of 1.5 μM and Power Sybr Green master mix
(Applied Biosystems) was used to perform PCR. Ampliﬁcation was
initiated at 95 °C for 10 min to activate the polymerase followed by 40
ampliﬁcation cycles [95 °C for 30 s, 54 °C for 45 s and 72 °C for 45 s].
Genome copy number was determined by comparison to a standard
curve plotted after ampliﬁcation of the same fragment from plasmid
pNTC244 at 10-fold serial dilutions starting from 1×1010 copies to
1×102 copies. All experimental and serial dilution templates were run
in triplicates. Data was analyzed using 7500 system SDS software
(Applied Biosystems).
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